[Featured Stock] Wellbiotech Hits Upper Limit Following Subsidiary Sale Decision
[Asia Economy Reporter Park So-yeon] Wellbiotech is hitting the upper price limit in early trading.
As of 9:38 AM on the 27th, Wellbiotech is trading at 1,995 KRW on the KOSPI market, up 460 KRW (29.97%) from the previous trading day.
On this day, Wellbiotech announced that it has decided to sell its subsidiary Geumyoung ENG to focus its capabilities on new business ventures.
Geumyoung ENG is a specialized company in cleanroom and dry room air conditioning equipment. Cleanrooms are workspaces that remove fine dust and bacteria, used not only for precision electronic products such as semiconductor devices and LCDs but also in ultra-fine industries like genetic engineering.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Wellbiotech has a market capitalization of 117.1 billion KRW and ranks 783rd on the KOSPI.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
